| License: Creative Commons Attribution 4.0 PDF - Published Version (643kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-521411
- DOI to cite this document:
- 10.5283/epub.52141
Mergenthaler, Philipp ; Stetefeld, Henning R. ; Dohmen, Christian ; Kohler, Siegfried ; Schönenberger, Silvia ; Bösel, Julian ; Gerner, Stefan T. ; Huttner, Hagen B. ; Schneider, Hauke ; Reichmann, Heinz ; Fuhrer, Hannah ; Berger, Benjamin ; Zinke, Jan ; Alberty, Anke ; Kleiter, Ingo ; Schneider-Gold, Christiane ; Roth, Christian ; Dunkel, Juliane ; Steinbrecher, Andreas ; Thieme, Andrea ; Lee, De-Hyung ; Linker, Ralf A. 
; Angstwurm, Klemens ; Meisel, Andreas ; Neumann, Bernhard
; Angstwurm, Klemens ; Meisel, Andreas ; Neumann, Bernhard Abstract
Myasthenic crisis (MC) is a life-threatening condition for patients with myasthenia gravis (MG). Seronegative patients represent around 10–15% of MG, but data on outcome of seronegative MCs are lacking. We performed a subgroup analysis of patients who presented with MC with either acetylcholine-receptor-antibody-positive MG (AChR-MG) or seronegative MG between 2006 and 2015 in a retrospective ...
Owner only: item control page
Download Statistics